02/14/2025
3:31 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:23 PM | Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
6:53 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:30 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
6:30 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form DEF 14A | |
01/15/2025
3:15 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form PRE 14A | |
12/19/2024
3:34 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/16/2024
3:09 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
6:38 PM | BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:15 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:16 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for SNTI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
12/10/2024
3:17 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:18 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/10/2024
3:19 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:18 PM | Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:02 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
7:26 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:51 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
3:32 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:05 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:42 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:19 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
3:17 PM | Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:30 PM | Mathers Edward T (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:07 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form DEF 14A | |
05/29/2024
3:09 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form DEFA14A | |
05/17/2024
4:17 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:19 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form PRE 14A | |
05/09/2024
3:19 PM | Li Yvonne (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:10 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:56 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
